Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The effect of theophylline and beta 2 agonists on airway reactivity Ahrens RC; Milavetz G; Joad JChest 1987[Jul]; 92 (1 Suppl): 15S-21SIncreased airway responsiveness occurs in asthma, chronic bronchitis, cystic fibrosis, and other diseases. Theophylline and beta 2 agonists commonly are used as maintenance therapy for symptoms associated with the increased responsiveness. Both drugs can reduce airway responsiveness to a variety of provocational stimuli. With currently used dosing regimens, theophylline appears to produce relatively constant levels of effect on airway responsiveness and clinical efficacy around the clock, while inhaled beta 2 agonists appear to have insufficient effects at the end of longer dosing intervals. Improved dosing strategies for beta 2 agonists may improve the efficacy of these agents in the future.|*Bronchial Provocation Tests[MESH]|Administration, Oral[MESH]|Adrenergic beta-Agonists/administration & dosage/*therapeutic use[MESH]|Adult[MESH]|Albuterol/administration & dosage[MESH]|Asthma/*drug therapy/physiopathology[MESH]|Clinical Trials as Topic[MESH]|Double-Blind Method[MESH]|Drug Evaluation[MESH]|Drug Therapy, Combination[MESH]|Forced Expiratory Volume[MESH]|Humans[MESH]|Respiratory Therapy[MESH]|Theophylline/administration & dosage/*therapeutic use[MESH] |
